Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis-Reference-Cited by-同舟云学术

Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis

Published:2016-10 Issue: Volume:220 Page:32-42
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Subban Vijayakumar^ORCID,Sengottuvelu Gunasekaran,Uthayakumaran Kalaichelvan,Rajendran Ravindran,Janakiraman Ezhilan,Pakshirajan Balaji,Thenpally Jose G.,Kalidoss Latchumanadhas,Victor Suma M.,Kalarickal Mathew Samuel,Ajit Mullasari S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Bioresorbable scaffolds: rationale, current status, challenges, and future;Iqbal;Eur. Heart J.,2014

2. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial;Onuma;JACC Cardiovasc. Interv.,2013

3. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes;Serruys;Circulation,2010

4. ABSORB EXTEND investigators. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled;Abizaid;EuroIntervention,2015

5. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance;Mattesini;JACC Cardiovasc. Interv.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study;Open Heart;2019-02